Meningitis is an inflammation of the meninges that cover and protect the brain and the spinal cord. This inflammation occurs upon an infection of the Central Nervous System (CNS), and etiological causes of infection can be bacteria, viruses, and in rare cases parasites. Pathogens in the brain encounter different types of cells, such as microglia, the resident macrophages of the brain, neurons, the fundamental cellular units responsible for electrical and chemical signaling, astrocytes, cells in close contact with the blood-brain barrier that participate in immune responses, and other infiltrating immune cells. The scope of this Research Topic was to shed light on all various types of interaction that the different etiological agents of meningitis (bacteria, viruses, parasites) take with the different cell types of the brain during the pathogenesis process.
Parasitic Meningitis
Meningitis caused by parasites does not always obtain enough attention from the scientific community. Parasites like Toxoplasma gondii can be resilient and have the capacity to cause lifelong chronic infections requiring continuous immune responses by the host. Bergersen et al. have provided a comprehensive study of how targeted transcriptomic analysis using mouse models of chronic T. gondii infection can reveal differences in the host and parasite gene expression, giving tremendous insights into how further understanding the neuropathology aspects of chronic T. gondii-CNS infection ().
Angiostrongylus cantonensis is another parasite that can cause meningitis, in particular the so-called eosinophilic meningitis. Yet, the pathogenesis of meningitis caused by A. cantonensis remains poorly understood. Zhang et al. have shown that upregulation of C-X3-C Motif Chemokine Ligand 1 (CX3CL1) in the brain tissue leads to the recruitment of natural killer (NK) cells into the CNS which of course should help the host in fighting the infection; however, this infiltration into the brain causes a worsening of the host CNS conditions (). Interestingly, Zhang et al. have observed that by neutralizing CX3CL1 and depleting NK cells, brain injury was alleviated, therefore proposing a new therapeutic intervention to protect the CNS against A. cantonensis infections ().
Viral Meningitis
Meningitis can also be caused by certain viruses. Dengue virus (DENV) is transmitted by Aedes mosquitoes to humans and is a serious threat worldwide. The main clinical problem is that, up to today, there is not an effective drug against dengue infections. Shen et al. have observed that metoclopramide (MCP), an antagonist of the dopamine 2 receptor (D2R) promotes an impairment of DENV-double-stranded RNA replication and provided promising results regarding the use of MCP as therapy to reduce DENV-induced neuronal damage ().
The Japanese encephalitis virus (JEV) can cause meningitis with permanent neurological sequelae and yet, the mechanism employed by JEV for brain invasion from the systemic circulation remained unknown. Zou et al. finally elucidated the mechanism of entering the brain by blood-borne JAV (). The virus uses monocytes to spread in the brain tissue and expand the infection in the CNS (). Furthermore, the extracellular High mobility group box protein 1 (HMGB1) facilitates the immune cell migration across the vascular endothelium of the BBB, which further accelerates the onset of JEV-induced meningitis ().
Viral meningitis represents a significant burden in tropical countries of South America, and Arboviruses, such as Chikungunya, Mayaro, Oropouche, and Zika viruses, are major etiological agents of this disease. Arbovirus-caused meningitis is also frequently associated with severe neurological outcomes. The comprehensive genome-wide transcriptome analysis of human primary astrocytes infected with Chikungunya, Mayaro, Oropouche, and Zika viruses described by Viana Geddes et al, has revealed a common pattern in downregulation of the host innate immune response, antiviral response, and expression levels of inflammatory cytokines associated with interferon stimulation for all the arboviruses tested (). These findings point towards a co-evolution that all these arboviruses have engaged in developing mechanisms to escape the antiviral response induced by interferon (IFN) (). Altogether, this expands the knowledge on how the antiviral-IFN pathway can be experimentally modified in order to be effective against Arbovirus-caused meningitis, opening avenues for novel clinical approaches ().
Bacterial Meningitis
Streptococcus pneumoniae (the pneumococcus) is the leading etiological cause of bacterial meningitis globally (). Despite access to antibiotics and the introduction of pneumococcal conjugate vaccine programs, mortality from pneumococcal meningitis exceeds 50% in sub-Saharan African countries with high HIV prevalence, and the causes of such high mortality are poorly understood. Wall et al. have interestingly reported that excessive S. pneumoniae elongation factor thermal unstable (EF-Tu) protein in the cerebrospinal fluid (CSF) was frequently associated with impaired survival in meningitis in a high HIV prevalence population (). Moreover, EF-Tu can inhibit neutrophil-mediated killing of S. pneumoniae in the CSF (). The findings by Wall et al. provide novel important knowledge on how pneumococci avoid essential host innate responses during meningitis pathogenesis ().
Microglia, the resident macrophages of the brain, initiate and drive the inflammatory process during pneumococcal meningitis pathogenesis. Pan et al. have reported that JWH-133, an agonist of G-protein cannabinoid receptor type 2 (CB2) impairs microglial activation and downregulates pro-inflammatory signaling (). Therefore, this important finding suggests that inhibition of microglial activation using CB2 agonists may represent a novel therapy for neuroinflammation modulation ().
Another major etiological agent of bacterial meningitis is Listeria monocytogenes. L. monocytogenes meningoencephalitis has a mortality rate of up to 50%, and severe neurofunctional sequelae are prevalent. Zbinden et al. have identified that L. monocytogenes expressing multiple sequence recognition (hsdS) A causes less damage than when other hsdS genes (B, C or D) are present (). On the other hand, the expression of hsdSC and D worsened the disease onset in L. monocytogenes meningitis (). This observation shows important phenotypical switching that has crucial role in regulating the virulence of CNS infections by L. monocytogenes (). Nevertheless, further studies are necessary to investigate how this therapy can also be effective in reducing brain injury.
Streptococcus suis (S. suis) is an important opportunistic pathogen, which can cause septicemia and meningitis in pigs, but also in humans. In the study by Lauer et al, using Gene Set Enrichment Analysis (GSEA), 18, 28, and 21 enriched hallmark gene sets (GSs) were identified for infected human choroid plexus (CP) epithelial papilloma (HIBCPP) cells, primary porcine CP epithelial cells (PCPEC), and in the CP of pigs affected by S. suis ST2 meningitis, respectively of which 8 GSs overlapped among the three different sample sets (). Most of these GSs were reported to be involved in cellular signaling, host immune and inflammatory response (). This finding clearly suggests that S. suis-infected human and porcine CP epithelial cells share similar cellular processes in the context of host inflammatory response ().
The pathogens covered in the study subject “Host-pathogen interaction in the Central Nervous System” are summarized in Figure 1.
Figure 1
Concluding Remarks
The Research Topic “Host-pathogen interaction in the Central Nervous System” also contains important review articles focused on i) the trans-endothelial trafficking of S. pneumoniae across the BBB endothelium (), ii) the molecular details of a broad array of CNS responses to the bacterial cell envelope and novel approaches to improve clinical outcome (), iii) the benefits and harms of the use of adjunctive steroid therapy to reduce neuroinflammation in meningitis patients (), iv) the beneficial or detrimental role of DNA sensors in viral CNS infections ().
Funding
This work was supported by The University of Texas Health Science Center at Houston. TB has received a grant from the Alzheimer’s Association (AARGDNTF-19-619645) and the National Institutes of Health/National Institute on Aging (NIH/NIA grant 1RF1AG072491). FI is funded by Karolinska Institutet Faculty Board, the Swedish Research Council (grant nr. 2020-0261), Bjarne Ahlström Foundation for Research in Clinical Neurology, Magnus Bergvall Foundation, Tore Nilson Foundation, Clas Groschinsky Foundation, and HKH Crown Princess Lovisa’s Association for Pediatric Research.
Publisher’s Note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Statements
Author contributions
TB and FI equally contributed to this editorial article. All authors contributed to the article and approved the submitted version.
Conflict of interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
References
1
AnilA.BanerjeeA. (2020). Pneumococcal Encounter With the Blood-Brain Barrier Endothelium. Front. Cell Infect. Microbiol.10, 590682. doi: 10.3389/fcimb.2020.590682
2
BergersenK.BarnesA.WorthD.DavidC.WilsonE. H. (2021). Targeted Transcriptomic Analysis of C57BL/6 and BALB/c Mice During Progressive Chronic Toxoplasma gondii Infection Reveals Changes in Host and Parasite Gene Expression Relating to Neuropathology and Resolution. Front. Cell Infect. Microbiol.11, 645778. doi: 10.3389/fcimb.2021.645778
3
GundamrajS.HasbunR. (2020). The Use of Adjunctive Steroids in Central Nervous Infections. Front. Cell Infect. Microbiol.10, 592017. doi: 10.3389/fcimb.2020.592017
4
IovinoF.SeinenJ.Henriques-NormarkB.van DijlJ. M. (2016). How Does Streptococcus Pneumoniae Invade the Brain? Trends Microbiol.24, 307–315. doi: 10.1016/j.tim.2015.12.012
5
JeffriesA. M.MarriottI. (2020). Cytosolic DNA Sensors and CNS Responses to Viral Pathogens. Front. Cell Infect. Microbiol.10, 576263. doi: 10.3389/fcimb.2020.576263
6
LauerA. N.ScholtysikR.BeinekeA.BaumsC. G.KloseK.Valentin-WeigandP.et al. (2021). A Comparative Transcriptome Analysis of Human and Porcine Choroid Plexus Cells in Response to Streptococcus Suis Serotype 2 Infection Points to a Role of Hypoxia. Front. Cell Infect. Microbiol.11, 639620. doi: 10.3389/fcimb.2021.639620
7
MaccainW. J.TuomanenE. I. (2020). Mini-Review: Bioactivities of Bacterial Cell Envelopes in the Central Nervous System. Front. Cell Infect. Microbiol.10, 588378. doi: 10.3389/fcimb.2020.588378
8
PanS. D.GrandgirardD.LeibS. L. (2020). Adjuvant Cannabinoid Receptor Type 2 Agonist Modulate the Polarization of Microglia Towards a Non-Inflammatory Phenotype in Experimental Pneumococcal Meningitis. Front. Cell Infect. Microbiol.10, 588195. doi: 10.3389/fcimb.2020.588195
9
ShenT. J.HanhV. T.NguyenT. Q.JhanM. K.HoM. R.LinC. F. (2021). Repurposing the Antiemetic Metoclopramide as an Antiviral Against Dengue Virus Infection in Neuronal Cells. Front. Cell Infect. Microbiol.10, 606743. doi: 10.3389/fcimb.2020.606743
10
GeddesV. E. V.BrustoliniO. J. B.CavalcanteL. T. F.MoreiraF. R. R.de CastroF. L.GuimarãesA. P. C.et al. (2021). Common Dysregulation of Innate Immunity Pathways in Human Primary Astrocytes Infected With Chikungunya, Mayaro, Oropouche, and Zika Viruses. Front. Cell Infect. Microbiol.11, 641261. doi: 10.3389/fcimb.2021.641261
11
WallE. C.BrownridgeP.LaingG.TerraV. S.MlozowaV.DenisB.et al. (2020). CSF Levels of Elongation Factor Tu Is Associated With Increased Mortality in Malawian Adults With Streptococcus Pneumoniae Meningitis. Front. Cell Infect. Microbiol.10, 603623. doi: 10.3389/fcimb.2020.603623
12
ZbindenF. R.De Ste CroixM.GrandgirardD.HaighR. D.VaccaI.ZamudioR.et al. (2020). Pathogenic Differences of Type 1 Restriction-Modification Allele Variants in Experimental Listeria Monocytogenes Meningitis. Front. Cell Infect. Microbiol.10, 590657. doi: 10.3389/fcimb.2020.590657
13
ZhangR.MiaoT.QinM.ZhaoC.WangW.ZhangC.et al. (2021). CX3 CL1 Recruits NK Cells Into the Central Nervous System and Aggravates Brain Injury of Mice Caused by Angiostrongylus Cantonensis Infection. Front. Cell Infect. Microbiol.11, 672720. doi: 10.3389/fcimb.2021.672720
14
ZouS. S.ZouQ. C.XiongW. J.CuiN. Y.WangK.LiuH. X.et al. (2021). Brain Microvascular Endothelial Cell-Derived HMGB1 Facilitates Monocyte Adhesion and Transmigration to Promote JEV Neuroinvasion. Front. Cell Infect. Microbiol.11, 701820. doi: 10.3389/fcimb.2021.701820
Summary
Keywords
Host-pathogen interaction, Central Nervous System, bacteria, viruses, parasites
Citation
Barichello T and Iovino F (2021) Editorial: Host-Pathogen Interaction in the Central Nervous System. Front. Cell. Infect. Microbiol. 11:790761. doi: 10.3389/fcimb.2021.790761
Received
07 October 2021
Accepted
25 November 2021
Published
24 December 2021
Volume
11 - 2021
Edited and reviewed by
Thomas Rudel, Julius Maximilian University of Würzburg, Germany
Updates
Copyright
© 2021 Barichello and Iovino.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Federico Iovino, federico.iovino@ki.se
This article was submitted to Bacteria and Host, a section of the journal Frontiers in Cellular and Infection Microbiology
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.